Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2003
07/10/2003US20030130304 Preventive or therapeutic agents for gastric or esophageal regurgitation
07/10/2003US20030130303 Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
07/10/2003US20030130301 Use of macrolide compounds for the treatment of dry eye
07/10/2003US20030130300 Respiratory system disorders; synergistic mixtures
07/10/2003US20030130299 Administering dosage of immunology response moderator
07/10/2003US20030130298 Autoimmune disease; grafting organs
07/10/2003US20030130297 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
07/10/2003US20030130296 FXR NR1H4 nuclear receptor binding compounds
07/10/2003US20030130295 Substituted 2-aminoacetamides and the use thereof
07/10/2003US20030130294 Pyrimidine 3-oxide compounds for inducing/stimulating hair growth and/or retarding hair loss
07/10/2003US20030130293 Detection defect in gene expression of hedgehog gene; diagnosis of cancer
07/10/2003US20030130292 Immunosuppressants; autoimmune disease; skin disorders; Crohn's disease; antidiabetic agents; anticancer agents; antiarthritic agents
07/10/2003US20030130289 Inhibitors of glycogen synthase kinase 3
07/10/2003US20030130288 Bronchitis; administering gemifloxalin
07/10/2003US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders
07/10/2003US20030130286 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents
07/10/2003US20030130285 Controlling cell differentiation, cell proliferation
07/10/2003US20030130284 Animal growth regulators; osteoporosis; congestive heart failure; muscular disorders
07/10/2003US20030130283 CRF receptor antagonists and methods relating thereto
07/10/2003US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
07/10/2003US20030130281 DPP IV inhibitors
07/10/2003US20030130280 Analyzing, prevention blood phosphorylation
07/10/2003US20030130279 Hyperglycemic agents; dietetics; cardiovascular disorders; immunology modulation; osteoporosis; cognition activators
07/10/2003US20030130277 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
07/10/2003US20030130276 Method of treating certain cancers using an estrogen agonist/antagonist
07/10/2003US20030130274 2-Phenyl-1-[4-(2-aminoethoxy)benzyl-indoles as estrogenic agents
07/10/2003US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030130272 Topoisomerase inhibitor; viricides
07/10/2003US20030130271 1,3-Diheterocyclic metalloprotease inhibitors
07/10/2003US20030130270 Heterocyclic derivatives and their use as antithrombotic agents
07/10/2003US20030130268 Mixture containing water soluble polymer and surfactant; antiinflammatory agents, antiulcer agents, Crohn's disease
07/10/2003US20030130267 Midazolane maleate in water, alcohol solution
07/10/2003US20030130266 Pharmacological treatment for sleep apnea
07/10/2003US20030130264 Methods of using pyrimidine-based antiviral agents
07/10/2003US20030130263 Mixture of two antihistamines; sustained release
07/10/2003US20030130262 Alzheimer's diseases; Down syndrome; brain disorders; psychological disorders
07/10/2003US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
07/10/2003US20030130260 Aryl fused azapolycyclic compounds
07/10/2003US20030130259 Quinoline and quinazoline compounds useful in therapy
07/10/2003US20030130258 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/10/2003US20030130256 Stimulant of central nervous system regeneration
07/10/2003US20030130255 Pyridoquinoxaline antivirals
07/10/2003US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents
07/10/2003US20030130253 Central nervous system disorders; skin disorders; appetite suppressants
07/10/2003US20030130252 Process for affecting neurologic progression
07/10/2003US20030130250 Methods to mobilize progenitor/stem cells
07/10/2003US20030130249 Therapeutic use of estrogen receptor (ER)beta-selective agonists for triggering somatotropic, organotropic and anticatabolic effects (somatotropic therapy)
07/10/2003US20030130248 Topical anti-inflammatory compositions
07/10/2003US20030130247 Compositions and methods for enhancing corticosteroid delivery
07/10/2003US20030130245 Stabilized aqueous suspensions for parenteral use
07/10/2003US20030130244 Mixture of estrogen, androgen and anticholinergic agent
07/10/2003US20030130243 Hormone replacement therapy
07/10/2003US20030130242 Administering hypocalcemic hydroxyvitamin d compound having ahydrocarbon moiety at the c-24 position as anticarcinogenic agent
07/10/2003US20030130241 Osteoporosis, parathyroid hormone disease, autoimmune disease
07/10/2003US20030130240 Skin disorders
07/10/2003US20030130239 Vision defects
07/10/2003US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/10/2003US20030130237 Lysophosphatidic acid receptor antagonist; anticancer agents
07/10/2003US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
07/10/2003US20030130235 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
07/10/2003US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect
07/10/2003US20030130231 2:1 Complex of beta- or gamma-cyclodextrin and alpha-tocopherol
07/10/2003US20030130230 Blocking cytokine, chemokines using oligosaccharides
07/10/2003US20030130229 Pharmaceutical compositions including alginates and methods of preparing and using same
07/10/2003US20030130228 Prevention of atherosclerosis and restenosis
07/10/2003US20030130227 Uridine derivatives as antibiotics
07/10/2003US20030130226 Prevent reproduction of viruses; genetic engineering
07/10/2003US20030130225 Urogenital disorders; concurrent administering fluconazole by mouth and topical applying fungicide in situ
07/10/2003US20030130218 Methods of stimulating phagocytosis
07/10/2003US20030130217 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
07/10/2003US20030130216 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease(cad) for treating cardiac disease
07/10/2003US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof
07/10/2003US20030130212 Administration of an anti-endotoxin drug by intravenous infusion
07/10/2003US20030130211 Injectable compositions for the controlled delivery of pharmacologically active compound
07/10/2003US20030130210 Method for treating a patient with neoplasia by treatment with an anthracycline antibiotic
07/10/2003US20030130209 Method of treatment of myocardial infarction
07/10/2003US20030130208 Preparation of fagopyritols and uses therefor
07/10/2003US20030130204 Antipicornaviral compounds and compositons, their pharmaceutical uses, and materials for their synthesis
07/10/2003US20030130203 Sleep disorders
07/10/2003US20030130201 Mixture with ascorbic acid, proline and lysine
07/10/2003US20030130199 Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
07/10/2003US20030130188 Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
07/10/2003US20030130186 Conjugates and compositions for cellular delivery
07/10/2003US20030130181 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130180 Utilization of an aminopeptidase inhibitor
07/10/2003US20030130178 Water soluble paclitaxel dervatives
07/10/2003US20030130173 Bactericides for drug resistant bacteria
07/10/2003US20030130170 Water soluble paclitaxel derivatives
07/10/2003US20030130169 Methods of treating drug-resistant bacterial infections
07/10/2003US20030130168 Reverse-turn mimetics and methods relating thereto
07/10/2003US20030130165 Method for treating neurodegenerative disorders
07/10/2003US20030130121 Novel bacterial isolate and the preparation and use of its active metabolites
07/10/2003US20030129752 MEKK/JNKK-contingent (mitogen extracellular signal regulated kinases (MEKK), Jun N-terminal kinase) signal transduction pathway; tumor necrosis factor; interleukins
07/10/2003US20030129733 Inactivated genomes of diploid microorganisms which are inducible into haploid forms; drug screening
07/10/2003US20030129728 Disrupting genes and mixing with plasmids/DNA vaccine; immunology; gene therapy; aging resistance
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129702 DNA encoding galanin GALR2 receptors and uses thereof
07/10/2003US20030129698 Involved in homo and heterotrimerization or oligomerization
07/10/2003US20030129678 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
07/10/2003US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
1 ... 5411 5412 5413 5414 5415 5416 5417 5418 5419 5420 5421 5422 5423 5424 5425 5426 5427 5428 5429 5430 5431 ... 7860